News Headlines

Display #
Title
U.S. SEC Warns Over Crypto ICO's & 'Potentially Unlawful' Celebrity Promotion
New tissue-engineered blood vessel replacements one step closer to human trials
Puerto Rico's Health Care Lessons
SAPVoice: Whatever The Question, AI Is The Answer Because Nobody Likes Calling Customer Service
Cigna Profits Rise As Obamacare Performance Improves
Boehringer Ingelheim expands collaboration with Sarah Cannon Research Institute to investigate novel immuno-oncology combination therapy
Alzheimer's disease might be a 'whole body' problem
The Origin Of Witches Riding Broomsticks: Drugs From Nature, Plus Shakespeare
Can The Feds Nail The Fentanyl Billionaire?
Medical Malpractice Claims Are Declining, But The Average Payment Is Rising
Any Breastfeeding -- Even If Combined With Formula -- Cuts SIDS Risk In Half
Food, Water, Shelter...Tech!
SAPVoice: IDC 2018 Predictions: If You're Not In The Cloud, You're Isolated From Innovation
Meet Two Millennial Founders Opening A Safe Home For Male Survivors Of Sex Trafficking
Health Insurance: The Scary Hole In America's Financial Plans
As Trump Prepares For Asia, A New Methodology: 'Exports Per Capita'
The U.S. Has A Fentanyl Shortage...In The Clinic, Not On The Streets
Court Says New Jersey Must Recognize 'Glaringly Apparent' Value Of Cannabis Medicine
Chinese Makers Of Illicit Fentanyl And Analogs Indicted For First Time
How Sexual Harassment May Actually Harm Your Heart
A New Test To Make Sure Your Beer Is Gluten Free
As CVS Deal Looms, Aetna Presses Medicare Advantage
'Precision Medicine' may not always be so precise
Scammers Used My Article And Montel's Name To Hock 'CBD'; Now It's Lawsuit Time
Half Of Patients With Super-High Cholesterol Can't Get Drugs That Could Help
Novartis announces the planned acquisition of Advanced Accelerator Applications to strengthen oncology portfolio
How Does Your Doctor's Webside Manner Compare To Their Bedside Manner?
These 5 Tips Can Make Your Halloween Safer
Infections And Deaths Mount In Puerto Rico As Hurricane-Related Risks Continue
Drugging The Undruggable: Kymera's Targeted Protein Degradation